Evidence map›Paper›PMID 31505630›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Declines in Pediatric Bacterial Meningitis in the Republic of Benin Following Introduction of Pneumococcal Conjugate Vaccine: Epidemiological and Etiological Findings, 2011-2016.

Joseph Agossou, Chinelo Ebruke, Alphonse Noudamadjo, Julien D Adédémy, Eric Y Dènon, Honoré S Bankolé, Mariam A Dogo, Rolande Assogba, Moussa Alassane, Abdoullah Condé and 14 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 3 institutions in 4 countries.

Joseph AgossouDepartment of Mother and Child, Faculty of Medicine, University of Parakou, Parakou, Benin.
Chinelo EbrukeWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, Banjul.
Alphonse NoudamadjoDepartment of Mother and Child, Faculty of Medicine, University of Parakou, Parakou, Benin.
Julien D AdédémyDepartment of Mother and Child, Faculty of Medicine, University of Parakou, Parakou, Benin.
Eric Y DènonService National de Laboratoire Sante Publique, Cotonou.
Honoré S BankoléService National de Laboratoire Sante Publique, Cotonou.
Mariam A DogoService National de Laboratoire Sante Publique, Cotonou.
Rolande AssogbaSaint Jean de Dieu Hospital of Tanguieta, Benin.
Moussa AlassaneSaint Jean de Dieu Hospital of Tanguieta, Benin.
Abdoullah CondéDepartment of Mother and Child, Faculty of Medicine, University of Parakou, Parakou, Benin.
Falilatou Agbeille MohamedDepartment of Mother and Child, Faculty of Medicine, University of Parakou, Parakou, Benin.
Gérard KpanidjaDepartment of Mother and Child, Faculty of Medicine, University of Parakou, Parakou, Benin.
Moutawakilou GominaBorgou Regional University Teaching Hospital, Parakou, Benin.
François HounsouService National de Laboratoire Sante Publique, Cotonou.
Basile G AouanouService National de Laboratoire Sante Publique, Cotonou.
Catherine OkoiWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, Banjul.
Claire OluwalanaWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, Banjul.
Archibald WorwuiWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, Banjul.
Peter S NdowWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, Banjul.
Jean NounagnonSaint Jean de Dieu Hospital of Tanguieta, Benin.
Jason M MwendaWHO Regional Office for Africa, Brazzaville, Republic of Congo.
Rock A SossouWHO Country Office, Cotonou, Benin.
Brenda A Kwambana-AdamsWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, Banjul.
Martin AntonioWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, Banjul.
MRC Unit the Gambia · GMUniversité de Parakou · BJWorld Health Organization Regional Office for Africa · CG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPediatric bacterial meningitis (PBM) remains an important cause of disease in children in Africa. We describe findings from sentinel site bacterial meningitis surveillance in children <5 years of age in the Republic of Benin, 2011-2016.

methodsCerebrospinal fluid (CSF) was collected from children admitted to Parakou, Natitingou, and Tanguieta sentinel hospitals with suspected meningitis. Identification of Streptococcus pneumoniae (pneumococcus), Haemophilus influenzae, and Neisseria meningitidis (meningococcus) was performed by rapid diagnostic tests, microbiological culture, and/or polymerase chain reaction; where possible, serotyping/grouping was performed.

resultsA total of 10 919 suspected cases of meningitis were admitted to the sentinel hospitals. Most patients were 0-11 months old (4863 [44.5%]) and there were 542 (5.0%) in-hospital deaths. Overall, 4168 CSF samples were screened for pathogens and a total of 194 (4.7%) PBM cases were confirmed, predominantly caused by pneumococcus (98 [50.5%]). Following pneumococcal conjugate vaccine (PCV) introduction in 2011, annual suspected meningitis cases and deaths (case fatality rate) progressively declined from 2534 to 1359 and from 164 (6.5%) to 14 (1.0%) in 2012 and 2016, respectively (P < .001). Additionally, there was a gradual decline in the proportion of meningitis cases caused by pneumococcus, from 77.3% (17/22) in 2011 to 32.4% (11/34) in 2016 (odds ratio, 7.11 [95% confidence interval, 2.08-24.30]). Haemophilus influenzae meningitis fluctuated over the surveillance period and was the predominant pathogen (16/34 [47.1%]) by 2016.

conclusionsThe observed decrease in pneumococcal meningitis after PCV introduction may be indicative of changing patterns of PBM etiology in Benin. Maintaining vigilant and effective surveillance is critical for understanding these changes and their wider public health implications.

Indexed as

Sentinel SurveillanceBeninChild, PreschoolFemaleHaemophilus influenzaeHumansInfantInfant, NewbornMaleMeningitis, BacterialNeisseria meningitidisPneumococcal VaccinesSerotypingStreptococcus pneumoniaeVaccines, ConjugatePneumococcal VaccinesVaccines, Conjugatebacterial meningitisBeninpediatricpneumococcusvaccines

Identifiers

PMID31505630
PMCPMC6761314
OpenAlexW2972018059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.